Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2025 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2025 Earnings Call Transcript November 12, 2025Acumen Pharmaceuticals, Inc. beats earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 14,932,063 | $25,533,828 | 0.31% | |
| 2. | Alyeska Investment Group Anand Parekh | 939,603 | $1,606,721 | 0% | |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 891,183 | $1,523,923 | -3% | 0.14% |
| 4. | Laurion Capital Management Benjamin A. Smith | 867,046 | $1,482,649 | 0.03% | |
| 5. | Hudson Bay Capital Management Sander Gerber | 725,004 | $1,239,757 | -13% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.75 | 5,161,290 | $39,999,997.50 | 13,043,179 | 2023-07-21 | Filing | |
| $16.00 | 35,000 | $560,000.00 | 172,324 | 2021-07-06 | Filing | |
| $16.00 | 312,500 | $5,000,000.00 | 3,352,693 | 2021-07-06 | Filing | |
| $16.00 | 750,000 | $12,000,000.00 | 3,951,156 | 2021-07-06 | Filing | |
| $16.00 | 6,250 | $100,000.00 | 6,250 | 2021-07-06 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 28,902 | $49,633.40 | 231,744 | 2025-01-23 | Filing | |
| $1.60 | 4,364 | $6,986.33 | 260,646 | 2025-01-21 | Filing | |
| $1.59 | 12,619 | $20,102.07 | 667,488 | 2025-01-21 | Filing | |
| $1.59 | 3,418 | $5,434.62 | 161,127 | 2025-01-21 | Filing | |
| $1.61 | 2,914 | $4,692.12 | 136,117 | 2025-01-21 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,417,075 | $5,843,198 | 1.28% | |
| 2. | 2,305,096 | $3,941,714 | 0% | |
| 3. | 2,029,325 | $3,470,146 | 0% | |
| 4. | 1,651,472 | $2,824,017 | 0% | |
| 5. | 1,628,510 | $2,784,752 | 0.25% |